Join Free For Buyer|Sign In

Professional Online Trade Platform for API, Preparation and Pharmaceutical Machinery and Equipment_EN-CPhI.cn

You are here:  Home >>  News >>  Market News >>  Perrigo rejects Mylan's acquisition bid

Perrigo rejects Mylan's acquisition bid

October 12, 2018 By biospectrumasia

Mylan has reproposed a price that is lower than the previously rejected proposal

Singapore: Irish firm, Perrigo, has declined the acquisition offer from Mylan revalued at USD60 per share in cash and 2.2 Mylan ordinary shares for each ordinary Perrigo share.

The Board previously concluded that Mylan's unsolicited proposal of USD205.00 per share significantly undervalued the company and its future growth prospects and was not in the best interests of Perrigo's shareholders.

Mylan has reproposed a price that is lower than the previously rejected proposal. Perrigo has advised its shareholders to take no action in relation to the Offer.

 

-------------------------------------------------

Editor's Note:

To apply for becoming a contributor of En-CPhI.cn,

welcome to send your CV and sample works to us,

Email: Julia.Zhang@ubmsinoexpo.com.
 

Readers'Comments
Add a comment
Click here to Login or to Register for free. You will be taken back to your selected item after Login/Registration.
More>> MarketNews
More>> Editors’Picks
More>> TopStories
More>> HotTags
Follow Us
CPhI Online Trade Platform: Worldwide|English|中国站
Customer Service:  86-400 610 1188 (9: 00-18: 00, Mon-Fri)
About Us| Contact Us| Terms of Services| Privacy Policy| Intellectual Property Statement| Links | Site Map
Copyright 2006-20 Shanghai UBM Sinoexpo International Exhibition Co Ltd (All Rights Reserved). ICP 05034851-53
web对话
live chat
客服对话